Hagens Berman Advises Investors of March 17, 2014, Deadline in Aegerion Pharmaceuticals, Inc. Securities Lawsuit and Investigation

[Business Wire] – Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating Aegerion Pharmaceuticals, Inc. for securities fraud following the news that the company illegally engaged in off-label marketing schemes and advises more

View todays social media effects on AEGR

View the latest stocks trending across Twitter. Click to view dashboard

See who Aegerion is hiring next, click here to view